MHRA joins Consortium of Regulators - without EU
Recommendation
11/12 February 2025
Heidelberg, Germany
Medicinal Products/Drugs meet Medical Devices
The U.K. Medicines and Healthcare products Regulatory Agency (MHRA) has joined the Australia-Canada-Singapore-Switzerland (ACSS) Consortium.
The ACSS consortium was formed in 2007 and comprised the national regulatory authorities of Australia, Canada, Singapore and Switzerland. Now, after MHRA has joined, the group's name was changed to 'Access'. The MHRA will commence work-sharing applications with Access partners from 1 January 2021. The members aim to promote greater regulatory collaboration and alignment of regulatory requirements. In this context he Access Consortium explores opportunities for information and work-sharing in areas including:
- generic medicines registration
- assessment reports for new prescription medicines
- information sharing and investigations into post-market medicine safety
- alignment of IT systems for information sharing
- development of technical guidelines.
Related GMP News
09.12.2024European Shortages Monitoring Platform (ESMP) has gone live
27.11.2024Windsor Framework Explainer Document published
27.11.2024EMA Comments on the Role of the QP in Supply Chain Traceability
20.11.2024The EU Qualified Person - What's it all about?
13.11.2024Glossary of ICH Terms and Definitions published
02.10.2024MHRA: New Rules for Manufacturers and Wholesalers after Brexit